Affordable Access

CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis.

Authors
  • Björnsson, E
  • Kilander, A
  • Olsson, R
Type
Published Article
Journal
Liver
Publication Date
Dec 01, 1999
Volume
19
Issue
6
Pages
501–508
Identifiers
PMID: 10661684
Source
Medline
License
Unknown

Abstract

Tumor markers as a diagnostic tool in diagnosing CC in patients with PSC are unfortunately not as valuable as previously reported. The serum levels of CA 19-9 can rise temporarily in association with a "biochemical relapse" of PSC (increased values of serum alkaline phosphatase). The marker product of CA 19-9 and CEA has a low sensitivity but a relatively high specificity for the detection of CC in PSC patients.

Report this publication

Statistics

Seen <100 times